Periodate-treated, non-anticoagulant heparin-carrying polystyrene (NAC-HCPS) affects angiogenesis and inhibits subcutaneous induced tumour growth and metastasis to the lung

被引:63
作者
Ono, K
Ishihara, M
Ishikawa, K
Ozeki, Y
Deguchi, H
Sato, M
Hashimoto, H
Saito, Y
Yura, H
Kurita, A
Maehara, T
机构
[1] Natl Def Med Coll, Res Inst, Div Biomed Engn, Tokorozawa, Saitama 3598513, Japan
[2] Natl Def Med Coll, Dept Surg 2, Tokorozawa, Saitama 3598513, Japan
[3] Natl Def Med Coll, Dept Surg 1, Tokorozawa, Saitama 3598513, Japan
[4] NeTech Inc, Kawasaki, Kanagawa 2130012, Japan
关键词
periodate-treated; non-anticoagulant heparin-carrying polystyrene (NAC-HCPS); heparin; angiogenesis; metastasis; tumour growth;
D O I
10.1038/sj.bjc.6600307
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Periodate-treated, non-anticoagulant heparin-carrying polystyrene consists of about ten periodate-oxidized, alkaline-degraded low molecular weight-heparin chains linked to a polystyrene core and has a markedly lower anti-coagulant activity than heparin. In this study, we evaluated the effect of non-anticoagulant heparin-carrying polystyrene on tumour growth and metastasis. Non-anticoagulant heparin-carrying polystyrene has a higher activity to inhibit vascular endothelial growth factor-165-, fibroblast growth factor-2- or hepatocyte growth factor-induced human microvascular endothelial cell growth than heparin, ten periodate-oxidized-heparin and ten periodate-oxidized-low molecular weight-heparin, which is probably due to the helparin-clustering effect of non-anticoagulant heparin-carrying polystyrene. Non-anticoagulant heparin-carrying polystyrene inhibited human microvascular endothelial cell, B 16 melanoma and Lewis lung cancer cell adhesion to Matrigel-coated plates, Non-anticoagulant heparin-carrying polystyrene also showed strong inhibitory activities in the tubular formation of endothelial cells on Matrigel and B16-melanoma and Lewis lung cancer cell invasion in a Matrigel-coated chamber assay. In vivo studies showed that growth of subcutaneous induced tumours and lung metastasis of B16-melanoma and Lewis lung cancer cells were more effectively inhibited by non-anticoagulant helparin-carrying polystyrene than ten periodate-oxidized-heparin and ten periodate-oxidized-low molecular weight-heparin. Furthermore, non-anticoagulant heparin-carrying polystyrene markedly reduced the number of CD34-positive vessels in subcutaneous Lewis lung cancer tumours, indicating a strong inhibition of angiogenesis. These results suggest that non-anticoagulant heparin-carrying polystyrene has an inhibitory activity on angiogenesis and tumour invasion and may be very useful in cancer therapy.
引用
收藏
页码:1803 / 1812
页数:10
相关论文
共 36 条
[21]   PROTEOGLYCANS - STRUCTURES AND INTERACTIONS [J].
KJELLEN, L ;
LINDAHL, U .
ANNUAL REVIEW OF BIOCHEMISTRY, 1991, 60 :443-475
[22]  
Kugler A, 1999, ANTICANCER RES, V19, P1589
[23]   Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties [J].
Lapierre, F ;
Holme, K ;
Lam, L ;
Tressler, RJ ;
Storm, N ;
Wee, J ;
Stack, RJ ;
Castellot, J ;
Tyrrell, DJ .
GLYCOBIOLOGY, 1996, 6 (03) :355-366
[24]  
Levine M, 1989, HEPARIN CHEM BIOL PR, P517
[25]   MORE TO HEPARIN THAN ANTICOAGULATION [J].
LINDAHL, U ;
LIDHOLT, K ;
SPILLMANN, D ;
KJELLEN, L .
THROMBOSIS RESEARCH, 1994, 75 (01) :1-32
[26]   CANCER CELL INVASION AND METASTASIS [J].
LIOTTA, LA .
SCIENTIFIC AMERICAN, 1992, 266 (02) :54-&
[27]   RGD-INDEPENDENT CELL-ADHESION TO THE CARBOXY-TERMINAL HEPARIN-BINDING FRAGMENT OF FIBRONECTIN INVOLVES HEPARIN-DEPENDENT AND HEPARIN-INDEPENDENT ACTIVITIES [J].
MCCARTHY, JB ;
SKUBITZ, APN ;
ZHAO, Q ;
YI, XY ;
MICKELSON, DJ ;
KLEIN, DJ ;
FURCHT, LT .
JOURNAL OF CELL BIOLOGY, 1990, 110 (03) :777-787
[28]   HEPARANASES AND TUMOR-METASTASIS [J].
NAKAJIMA, M ;
IRIMURA, T ;
NICOLSON, GL .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1988, 36 (02) :157-167
[29]   The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration [J].
Nehls, V ;
Herrmann, R .
MICROVASCULAR RESEARCH, 1996, 51 (03) :347-364
[30]   Ribozyme approach to downregulate vascular endothelial growth factor (VEGF) 189 expression in non-small cell lung cancer (NSCLC) [J].
Oshika, Y ;
Nakamura, M ;
Tokunaga, T ;
Ohnishi, Y ;
Abe, Y ;
Tsuchida, T ;
Tomii, Y ;
Kijima, H ;
Yamazaki, H ;
Ozeki, Y ;
Tamaoki, N ;
Ueyama, Y .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (18) :2390-2396